Launxp Biomedical Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Launxp Biomedical Co Ltd

Watchlist Manager

Watchlist

Price: 9.9 TWD -5.71% Market Closed

Market Cap: NT$699.9m

L	Launxp Biomedical Co Ltd TPEX:6876	TW
	White Gold Corp. XTSX:WGO	CA
Q	Q Interline A/S CSE:QINTER	DK
S	SSR Inc KOSDAQ:275630	KR
	Fast Ejendom Danmark A/S CSE:FED	DK
A	Actuate Therapeutics Inc NASDAQ:ACTU	US
E	E&E Recycling Inc TPEX:8440	TW
	Vertical Exploration Inc XTSX:VERT	CA
B	Biolog Device Co Ltd KOSDAQ:208710	KR
	BiVictriX Therapeutics PLC LSE:BVX	UK
B	Belluscura PLC LSE:BELL	UK
	Jiangsu Amer New Material Co Ltd SZSE:002201	CN

Profitability Summary

Launxp Biomedical Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Sustainable 3Y Average Gross Margin

31%

Low Operating Margin

Negative 3Y Average Operating Margin

-247 915%

Low Net Margin

Negative 3Y Average Net Margin

-247 613%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-191 211%

Negative ROE

-45%

Negative 3Y Average ROE

-64%

Negative ROIC

-57%

Negative 3Y Average ROIC

-278%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.